Scientists from Latvia invented medicine for treatment of peripheral T-cell lymphoma. This form of cancer occurs quite frequently, and poorly to conventional therapy. The development of a drug, scientists have gone 13 years now means tested and certified.
The drug was named belinostat. Every tenth patient with lymphoma who took the drug during the study, completely recovered. Opening means against cancer is a real achievement for scientists from Latvia, notes Ivars Kalvinsh, Director of IOS.
Now it's time for investors. Production belinostat require large financial investments. The first investment was made by the Americans who plan to support the development.
Read also: Ecstasy as a drug against cancer
Now the work of scholars that examine the effectiveness belinostat against another 11 forms of cancer.